Similarly to other immune checkpoint ligands, TIGIT ligands are often overexpressed in cancer cells [15–18] while TIGIT is significantly upregulated in chronically stimulated or exhausted tumor-infiltrating T cells [14, 19, 20]. This evidence concerns the gene TIGIT and cancer.